Patented AI Platform Identifies Promising BioPharma Assets

Cover Image
Read how Intelligencia AI has taken a robust and scientifically sound approach to data and AI quality by prospectively validating algorithms through monitoring predictions of drug approval success over time. Prospective validation is the hard currency for AI. This article talks about that exact topic and the power of leveraging accurate, AI-driven probability of technical and regulatory success (PTRS) assessments to identify promising early-stage biopharma assets and companies—even sooner and more confidently.  
Vendor:
Intelligencia AI
Posted:
Oct 11, 2024
Published:
Aug 29, 2024
Format:
HTML
Type:
Blog
Already a Bitpipe member? Log in here

Download this Blog!